Neoadjuvant hormonal deprivation in locally advanced prostate cancer: does it make sense?
Schulman
C C
CC
Department of Urology, University Clinics of Brussels, Erasme Hospital, Belgium.
Wildschutz
T P
TP
D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D009361:Neoplasm Invasiveness; D011292:Premedication; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D004967:Estrogens; D004054:Diethylstilbestrol